Sangamo Therapeutics (SGMOQ) Cash from Investing Activities Growth (3y) (2013 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Cash from Investing Activities Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.13 Bn | 9.29 Bn | 112.79 Mn | -116.35% |
| 2 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn | 22.12% |
| 4 | Legend Biotech | 3.68 Bn | 2.72 Bn | 251.50 Mn | 0.46% |
| 5 | uniQure | 3.08 Bn | 3.08 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | -43.68% |
| 9 | Vericel | 2.00 Bn | 1.84 Bn | 56.40 Mn | -5.41% |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | -26.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -26.00% |
| Sep 30, 2025 | 83.19% |
| Jun 30, 2025 | -26.01% |
| Dec 31, 2024 | -70.70% |
| Sep 30, 2024 | -84.37% |
| Jun 30, 2024 | -88.75% |
| Mar 31, 2024 | -7.50% |
| Dec 31, 2023 | 31.79% |
| Sep 30, 2023 | 29.17% |
| Jun 30, 2023 | -18.21% |
| Mar 31, 2023 | 14.63% |
| Sep 30, 2022 | 32.31% |
| Jun 30, 2022 | 44.96% |
| Mar 31, 2022 | 28.37% |
| Dec 31, 2021 | -5.73% |
| Sep 30, 2021 | -9.68% |
| Jun 30, 2021 | 31.73% |
| Mar 31, 2021 | 80.85% |
| Dec 31, 2020 | -88.18% |
| Sep 30, 2020 | -107.70% |